Cancer.
Insights.
Cures.

Aster Insights partners with drug, biologics, diagnostics, and medical device developers to accelerate oncology product discovery and development through our scientific and clinical intelligence.

Together we can make an impact.

A growing foundation of nearly half a million patients as partners

Multimodal scientific and clinical intelligence

Forward-thinking, patient-focused research

Novel insights for tomorrow's cures

Together, we are changing the way cancer is studied, treated, and prevented

OUR HISTORY

Long-Time Innovator in Oncology

2006

M2GEN (now Aster Insights) is founded
First patient enrolled in Total Cancer Care® (TCC)

2012

Merck uses our data to lay path for KEYTRUDA® development

2014

Oncology Research Information Exchange Network (ORIEN®) consortium established

2018

ORIEN® expands and adds community partnership

2021

Exceeded 100 publications from TCC®

2022

Exceeded 150 cumulative ORIEN® research collaborations

2023

400,000 patients accrued in TCC®